Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nanchen

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Preventive Medicine Reports|January 3, 2022
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in SwitzerlandInge Worni-Schudel, Vasilis Tzalis, Julian Jakob, et al.
Circulation. Heart Failure|April 20, 2013
Resting heart rate and the risk of heart failure in healthy adults: the Rotterdam StudyDavid Nanchen, Maarten J G Leening, Isabella Locatelli, et al.
European Heart Journal|December 15, 2015
Prognostic value of PCSK9 levels in patients with acute coronary syndromesBaris Gencer, Fabrizio Montecucco, David Nanchen, et al.
Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular riskDavid Nanchen, Jacobijn Gussekloo, Rudi G J Westendorp, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Cardiovascular Diabetology|November 2, 2019
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61Patric Winzap, Allan Davies, Roland Klingenberg, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic DissectionAnja Forrer, Felix Schoenrath, Michael Torzewski, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Preventive Medicine Reports|January 3, 2022
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in SwitzerlandInge Worni-Schudel, Vasilis Tzalis, Julian Jakob, et al.
Circulation. Heart Failure|April 20, 2013
Resting heart rate and the risk of heart failure in healthy adults: the Rotterdam StudyDavid Nanchen, Maarten J G Leening, Isabella Locatelli, et al.
European Heart Journal|December 15, 2015
Prognostic value of PCSK9 levels in patients with acute coronary syndromesBaris Gencer, Fabrizio Montecucco, David Nanchen, et al.
Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular riskDavid Nanchen, Jacobijn Gussekloo, Rudi G J Westendorp, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Cardiovascular Diabetology|November 2, 2019
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61Patric Winzap, Allan Davies, Roland Klingenberg, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic DissectionAnja Forrer, Felix Schoenrath, Michael Torzewski, et al.
Pageof 14